Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
Order: Signal: Tickers:
Filters
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Stats
Total: 200 #1 Type: candle | line | technical    Timeframe: daily | intraday    Auto Refresh: 3min | off
TickerSAVA [NASD]
CompanyCassava Sciences, Inc.
CountryUSA
IndustryBiotechnology
Market Cap78.19MEPS (ttm)-0.22
P/E-EPS this Y56.70%
Forward P/E-EPS next Y-25.90%
PEG-EPS past 5Y32.60%
P/S-EPS next 5Y-
P/B3.39EPS Q/Q25.70%
Dividend-Sales Q/Q-
Insider Own10.47%Inst Own25.20%
Insider Trans0.00%Inst Trans-0.02%
Short Float13.52%EarningsAug 12/b
Analyst Recom3.00Target Price-
Avg Volume1.74M52W Range1.05 - 10.95
Sep-14-20 12:44PMCassava Sciences rockets on heavy volume after Alzheimer's drug trial results prompts analyst upgrade MarketWatch
Sep-14-20 07:15AMCassava Sciences Announces Final Results of a Phase 2b Clinical Study of Sumifilam in Patients with Alzheimers Disease GlobeNewswire
Sep-11-20 04:01PMCassava Sciences to Hold Conference Call on Monday, September 14, 2020 at 8:30 am ET GlobeNewswire
Sep-09-20 08:15AMCassava Sciences to Present at H.C. Wainwrights 22nd Annual Global Investment Conference GlobeNewswire
Sep-03-20 08:15AMCassava Sciences Announces New Patent Grant GlobeNewswire
Aug-24-20 08:15AMCassava Sciences Announces Lead Drug Candidate PTI-125 Is Assigned the Chemical Drug Name sumifilam by USAN GlobeNewswire
Aug-12-20 08:15AMCassava Sciences Announces Second Quarter 2020 Financial Results and Mid-year Business Review GlobeNewswire
Jul-14-20 08:44AMCassava Sciences (SAVA) Jumps: Stock Rises 9.2% Zacks
Jul-09-20 04:01PMCassava Sciences to Give Keynote Presentation on SavaDx at a Scientific Conference GlobeNewswire
Jun-16-20 08:15AMCassava Sciences Added to Russell Indexes and Provides Phase 2b Study Update GlobeNewswire
TickerIMMU [NASD]
CompanyImmunomedics, Inc.
CountryUSA
IndustryBiotechnology
Market Cap9.69BEPS (ttm)-1.72
P/E-EPS this Y-120.60%
Forward P/E-EPS next Y50.90%
PEG-EPS past 5Y-29.10%
P/S475.08EPS next 5Y64.80%
P/B16.06EPS Q/Q25.50%
Dividend-Sales Q/Q-
Insider Own0.10%Inst Own90.70%
Insider Trans-Inst Trans15.53%
Short Float12.72%EarningsAug 05/a
Analyst Recom1.80Target Price52.24
Avg Volume2.54M52W Range8.80 - 45.69
Sep-14-20 12:48PMCoronavirus update: AstraZeneca resumes vaccine trial as Gilead drug gets a boost from Lilly Yahoo Finance
Sep-14-20 12:46PMImmunomedics, Scientific Games: 5 Top Gainers for Monday TheStreet.com
Sep-14-20 12:42PMStocks Charge Higher on M&A News and Vaccine Progress TheStreet.com
Sep-14-20 11:42AMThis Merger Monday Is Nothing to Cheer About Bloomberg
Sep-14-20 11:26AMStock market news live updates: Stocks rise as vaccine, merger news draw focus Yahoo Finance
Sep-14-20 10:49AMGilead Makes Its Biggest Buy Ever And Gets A 'Flagship' Cancer Drug Investor's Business Daily
Sep-14-20 10:28AMGilead Just Made a Big Bet on Immunomedics Cancer Treatment. Was the Price too High? Barrons.com
Sep-14-20 10:03AMGilead Ramps Up Cancer Focus With $21 Billion Immunomedics Deal Bloomberg
Sep-14-20 10:03AMDealmakers See $69 Billion of M&A in Years Busiest Weekend Bloomberg
Sep-14-20 10:03AMGilead Sciences Agrees $21 Billion Takeover Of Cancer Drug Specialist Immunomedics TheStreet.com
TickerBCYC [NASD]
CompanyBicycle Therapeutics plc
CountryUnited Kingdom
IndustryBiotechnology
Market Cap318.16MEPS (ttm)-2.07
P/E-EPS this Y-124.50%
Forward P/E-EPS next Y-17.10%
PEG-EPS past 5Y-
P/S37.00EPS next 5Y-
P/B3.98EPS Q/Q-17.40%
Dividend-Sales Q/Q6.70%
Insider Own0.90%Inst Own32.90%
Insider Trans0.00%Inst Trans5.79%
Short Float3.56%Earnings-
Analyst Recom1.60Target Price23.86
Avg Volume46.94K52W Range7.50 - 20.10
Sep-14-20 06:59AMBicycle Therapeutics to Present Trials in Progress Poster for BT8009 at the ESMO Virtual Congress 2020 Business Wire
Sep-10-20 04:05PMBicycle Therapeutics Announces First Patient Dosed in Phase I/II Trial of Bicycle® Toxin Conjugate BT8009 in Patients with Advanced Solid Tumors Business Wire
Sep-03-20 06:59AMBicycle Therapeutics to Participate in Upcoming Virtual Investor Conferences Business Wire
Sep-02-20 06:59AMBicycle Therapeutics Announces First Patient Dosed in Phase IIa Trial of Bicycle® Toxin Conjugate BT1718 Business Wire
Sep-01-20 06:59AMBicycle Therapeutics Announces First Patient Dosed in Oxurions Phase II Trial Using a Novel Bicycle®-based Plasma Kallikrein Inhibitor for the Treatment of Diabetic Macular Edema Business Wire
Aug-06-20 08:03AMInvestors Who Bought Bicycle Therapeutics (NASDAQ:BCYC) Shares A Year Ago Are Now Up 122% Simply Wall St.
Aug-05-20 04:05PMBicycle Therapeutics to Present at the Canaccord Genuity 40th Annual Growth Conference Business Wire
Aug-05-20 06:59AMBicycle Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update Business Wire
Jun-24-20 08:37AMBicycle Therapeutics (BCYC) Catches Eye: Stock Jumps 8.9% Zacks
Jun-23-20 06:59AMBicycle Therapeutics Appoints Sir Keith Peters as Chairman of Its Scientific Advisory Board Business Wire
TickerKFYP [NYSE]
CompanyKraneShares CICC China Leaders 100 Index ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend0.20%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume2.83K52W Range23.01 - 31.29
Jan-27-20 03:17PMChina ETFs Back Off Economic Growth Concerns in Wake of Coronavirus ETF Trends
Oct-28-19 08:40AMKraneShares Joins Forces With Dorsey Wright For ETF Rotation Model Benzinga
Oct-23-19 08:00AMKraneShares Joins with Nasdaq Dorsey Wright to Launch KraneShares China Rotation Model PR Newswire
Jun-11-19 04:05PMChina ETFs Surge on Infrastructure Stimulus ETF Trends
May-16-19 01:12AMChina Disappoints With Sluggish Numbers: 5 ETFs in Focus Zacks
Apr-18-19 05:26PMChina's Economy Beats Growth Forecasts: 5 ETFs in Focus Zacks
Jan-24-19 08:00AMChina's 2018 GDP Growth 28-Year Low: ETFs That Lost the Most Zacks
Jul-12-18 06:11PMChina ETFs: Buy the Dip? Zacks
Oct-18-17 03:57PMFollow These ETFs as China's 19th National Congress Begins Zacks
Jul-11-17 08:26AMChinese Investment Bank Takes Majority Stake In KraneShares Benzinga
TickerDVOL [NASD]
CompanyFirst Trust Dorsey Wright Momentum & Low Volatility ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend1.91%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume43.97K52W Range14.65 - 24.28
Sep-13-19 04:58PMLow-Volatility ETFs to Sail Through Trade War Uncertainty Zacks
Aug-30-19 08:00AMMomentum ETFs to Buy as US-China Adopt Peacemaking Tone Zacks
TickerYI [NASD]
Company111, Inc.
CountryChina
IndustryHealth Information Services
Market Cap470.00MEPS (ttm)-0.89
P/E-EPS this Y-31.00%
Forward P/E-EPS next Y27.30%
PEG-EPS past 5Y-
P/S0.57EPS next 5Y-
P/B5.25EPS Q/Q8.10%
Dividend-Sales Q/Q93.50%
Insider Own-Inst Own7.50%
Insider Trans-Inst Trans10.71%
Short Float0.16%EarningsAug 20/b
Analyst Recom1.50Target Price-
Avg Volume107.71K52W Range4.26 - 8.70
Sep-04-20 06:22AM111, Inc. Partners with Baiyunshan Pharmaceutical Sales in Digital Medicine Innovation PR Newswire
Aug-20-20 04:35AM111, Inc. Announces Second Quarter 2020 Unaudited Financial Results PR Newswire
Aug-20-20 04:30AM111, Inc. Announces New Capital Injection and Strategic Plan to Expand Access to China's Capital Markets PR Newswire
Jul-31-20 06:00AM111 to Announce Second Quarter 2020 Unaudited Financial Results on August 20, 2020 PR Newswire
Jul-27-20 06:00AM111, Inc. Launched Lung Cancer Patient Care Program "Cloud Enabled Lung Cancer Care by Great Doctors" for Full Life-cycle Management of Tumor PR Newswire
May-27-20 03:44PMHere is How Hedge Funds Traded 111, Inc. (YI) During The Crash Insider Monkey
May-21-20 04:30AM111, Inc. Announces First Quarter 2020 Unaudited Financial Results PR Newswire
May-15-20 11:55AMIs 111 (NASDAQ:YI) Using Debt In A Risky Way? Simply Wall St.
May-08-20 06:00AM111 to Launch First Online Diabetes Patient Management Platform with Lilly China PR Newswire
May-07-20 05:55AM111 to Announce First Quarter 2020 Unaudited Financial Results on May 21, 2020 PR Newswire
TickerQED [NYSE]
CompanyIQ Hedge Event-Driven Tracker ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend2.04%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume1.25K52W Range17.70 - 24.40
Mar-17-20 04:00PMAlternative ETF Strategies to Prep a Portfolio For Unknowns ETF Database
Nov-18-19 05:05PMLiquid Alternative ETFs: The Institutional Perspective ETF Trends
Oct-03-19 12:31PMIndexIQ Joins With Nasdaq Dorsey Wright to Launch First Liquid Alternative ETF Model Business Wire
Dec-19-18 03:05PMA Year in Review: ETF Ideas for 2019 ETF Trends
Dec-13-18 05:42PMA Year in Review: ETF Ideas for 2019 ETF Trends
Apr-30-18 10:06AMIndexIQ And Chaikin Analytics To Ring The Opening Bell At Nasdaq On Monday, April 30th PR Newswire
Jan-08-18 01:00PMNew York Life Investment Management Announces New Leadership Team at IndexIQ PR Newswire
Dec-13-17 04:03PMIndexIQ Launches The IQ Chaikin U.S. Large Cap ETF (CLRG) PR Newswire
Oct-23-17 12:59PMIndexIQ Reduces Fees For IQ Hedge Multi-Strategy Tracker ETF (QAI) PR Newswire
Oct-18-17 02:40PMIndexIQ Launches Two Actively Managed Municipal Bond ETFs PR Newswire
TickerUIVM [NYSE]
CompanyVictoryShares USAA MSCI International Value Momentum ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend3.18%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume8.72K52W Range29.76 - 46.62
Jun-25-19 05:29PMSmart Beta ETF Opportunities for Todays Market ETF Database
Apr-18-19 02:59PMSmart Beta ETFs Are Not Created Equal ETF Database
Apr-18-19 02:39PMSmart Beta ETFs Are Not Created Equal, So Look Under the Hood ETF Trends
TickerSGMS [NASD]
CompanyScientific Games Corporation
CountryUSA
IndustryGambling
Market Cap1.82BEPS (ttm)-4.14
P/E-EPS this Y63.90%
Forward P/E46.16EPS next Y108.80%
PEG-EPS past 5Y12.80%
P/S0.61EPS next 5Y-
P/B-EPS Q/Q-158.10%
Dividend-Sales Q/Q-36.20%
Insider Own1.30%Inst Own60.90%
Insider Trans0.00%Inst Trans0.24%
Short Float12.53%EarningsJul 23/a
Analyst Recom2.60Target Price16.78
Avg Volume1.21M52W Range3.76 - 31.63
Sep-14-20 12:46PMImmunomedics, Scientific Games: 5 Top Gainers for Monday TheStreet.com
Sep-14-20 11:09AMWhy Shares of Scientific Games Jumped 51.7% on Monday Motley Fool
Sep-14-20 10:51AMPerelman Nears Scientific Games Stake Sale to Caledonia Bloomberg
Sep-14-20 07:52AMScientific Games Pops 15% After Caledonia, Investors Snap Up 34.9% Stake SmarterAnalyst
Sep-14-20 07:22AMScientific Games to sell 34.9% stake to Caledonia, other investors Reuters
Sep-14-20 06:15AMScientific Games Announces Institutional Investors, including Caledonia, to Acquire 34.9% Shareholding from MacAndrews & Forbes PR Newswire
Sep-08-20 03:08PMWho Has Been Buying Scientific Games Corporation (NASDAQ:SGMS) Shares? Simply Wall St.
Sep-02-20 09:00AMWynn Resorts and Scientific Games Launch Partnership in New Jersey and Extend to Colorado and Indiana PR Newswire
Sep-01-20 09:35AMScientific Games Lottery Group Chief Executive Pat McHugh to be Inducted Into Lottery Industry Hall of Fame PR Newswire
Aug-28-20 01:01PMScientific Games Sees IBD RS Rating Improve To 75 Investor's Business Daily
TickerARCO [NYSE]
CompanyArcos Dorados Holdings Inc.
CountryUruguay
IndustryRestaurants
Market Cap888.71MEPS (ttm)-0.41
P/E-EPS this Y122.60%
Forward P/E37.66EPS next Y114.10%
PEG-EPS past 5Y22.40%
P/S0.37EPS next 5Y16.50%
P/B5.22EPS Q/Q-960.20%
Dividend3.83%Sales Q/Q-59.60%
Insider Own4.30%Inst Own84.40%
Insider Trans0.00%Inst Trans1.86%
Short Float1.31%EarningsAug 12/b
Analyst Recom1.90Target Price6.23
Avg Volume1.04M52W Range2.92 - 8.29
Sep-11-20 08:00AMArcos Dorados to Participate in Upcoming Investor Conferences Business Wire
Sep-10-20 09:52PMArcos Dorados Announces Pricing of its 5.875% Senior Notes due 2027 Business Wire
Sep-08-20 11:56AMArcos Dorados Holdings Inc. -- Moody's: Arcos Dorados Ba2 ratings and negative outlook unaffected by notes add-on Moody's
Sep-08-20 08:45AMArcos Dorados Announces Proposed Offering of Senior Notes Business Wire
Aug-17-20 10:56AMArcos Dorados Holdings (NYSE:ARCO) Shareholders Have Enjoyed A 50% Share Price Gain Simply Wall St.
Aug-12-20 04:00PMArcos Dorados Holdings Inc (ARCO) Q2 2020 Earnings Call Transcript Motley Fool
Aug-12-20 08:45AMArcos Dorados (ARCO) Reports Q2 Loss, Tops Revenue Estimates Zacks
Aug-12-20 07:53AMArcos Dorados: Q2 Earnings Insights Benzinga
Aug-12-20 07:30AMArcos Dorados Reports Second Quarter 2020 Financial Results Business Wire
Aug-11-20 10:16AMEarnings Outlook For Arcos Dorados Holdings Benzinga
123456 ... 10 ... 20next